hotspot -WSS

hotspot

author：entertainment 2025-09-30 16:28:43 - browse：58

Blue CAR-T cell attacks a leukemia cell. --health coverage from STAT — Engineered receptors on the surface of a T-lymphocyte bind to a leukemia cell. Adobe

The announcement on Tuesday that the Food and Drug Administration was investigating whether CAR-T immunotherapy had itself caused blood cancers initially appeared to be a significant blow to one of the brightest spots in cancer care.

But experts quickly cautioned that risk of this complication is probably minuscule compared to the known risk of secondary cancers from other cancer therapies like chemotherapy and radiation. They noted that CAR-T cells are immune cells that are genetically engineered to fight cancer, and that such genetic modifications were long thought to carry a risk of causing a second, new cancer in patients. The surprise, in a way, is that since CAR-T was first invented more than 10 years ago, that risk had remained just theoretical.

“There’s been a requirement for long-term follow up. I think this is why we’re all surprised. As far as I think any one of us knew, it’d never happened with any of the FDA-approved CAR-Ts,” said Marcela Maus, a cell therapy researcher at Mass General Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： A new crop of companies is reshaping the health data economy

WSS

Congressmen charge Covid hearing ‘could have been an email’

Cybersecurity threat forces Lurie Children's to take systems offline

Biden administration opens offers in Medicare drug price negotiations

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

Vertigo drug brings hope for rare neuron disorder, Niemann

SAMSHA loosens regulations on methadone treatment centers

focus

hotspot

hotspot

Walensky prepares to leave CDC — and Congress — behind

New lawsuit accuses health insurer Cigna of denying claims in bulk

Peter Hotez and the public health issue of online harassment

Dems pitch expanding Medicare power to negotiate drug prices

George Santos makes 1st court appearance after pleading not guilty to 13 counts

A new crop of companies is reshaping the health data economy

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Truvian presents data for its desktop blood

New air purifier tech could be key to improving indoor air quality

Democrats decry new health bill for going easy on private equity

focus

Time to name cancers by genetics, not organ of origin, expert says

Vertigo drug brings hope for rare neuron disorder, Niemann

Medicare drug price negotiation’s day in court

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

What we need to know about Arena Bioworks

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

focus

leisure time

knowledge

focus